This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988;24(1):31-8.

Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment

T Crook

PMID: 3290945

Review

Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment

T Crook. Psychopharmacol Bull. 1988.

. 1988;24(1):31-8.

Author

T Crook

PMID: 3290945

No abstract available

PubMed Disclaimer

Similar articles

Memory problems in dementia: adaptation and coping strategies and psychosocial treatments.
Dröes RM, van der Roest HG, van Mierlo L, Meiland FJ. Dröes RM, et al. Expert Rev Neurother. 2011 Dec;11(12):1769-81; quiz 1782. doi: 10.1586/ern.11.167. Expert Rev Neurother. 2011. PMID: 22091600 Review.
Effects of beta-hydroxybutyrate on cognition in memory-impaired adults.
Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S. Reger MA, et al. Neurobiol Aging. 2004 Mar;25(3):311-4. doi: 10.1016/S0197-4580(03)00087-3. Neurobiol Aging. 2004. PMID: 15123336 Clinical Trial.
Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K. Kashiwa Y, et al. Psychiatry Clin Neurosci. 2005 Dec;59(6):697-704. doi: 10.1111/j.1440-1819.2005.01439.x. Psychiatry Clin Neurosci. 2005. PMID: 16401246
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.
Santucci AC, Haroutunian V, Tsuboyama GK, Kanof PD, Davis KL. Santucci AC, et al. Prog Clin Biol Res. 1989;317:1111-20. Prog Clin Biol Res. 1989. PMID: 2690088 Review. No abstract available.
Rofecoxib in mild cognitive impairment.
Ownby RL. Ownby RL. Curr Psychiatry Rep. 2006 Feb;8(1):9-10. Curr Psychiatry Rep. 2006. PMID: 16513035 Clinical Trial. No abstract available.

See all similar articles

Cited by

Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
Byrne EJ, Arie T. Byrne EJ, et al. BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132. BMJ. 1990. PMID: 2160850 Free PMC article. Clinical Trial. No abstract available.
Co-dergocrine mesylate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in age-related cognitive decline.
Wadworth AN, Chrisp P. Wadworth AN, et al. Drugs Aging. 1992 May-Jun;2(3):153-73. doi: 10.2165/00002512-199202030-00002. Drugs Aging. 1992. PMID: 1606351 Review.
Ginkgo biloba extract and cognitive decline.
Warburton DM. Warburton DM. Br J Clin Pharmacol. 1993 Aug;36(2):137. doi: 10.1111/j.1365-2125.1993.tb04213.x. Br J Clin Pharmacol. 1993. PMID: 8398586 Free PMC article. No abstract available.
Tetrahydroaminoacridine (THA) in Alzheimer's disease.
Byrne J, Arie T. Byrne J, et al. BMJ. 1989 Apr 1;298(6677):845-6. doi: 10.1136/bmj.298.6677.845. BMJ. 1989. PMID: 2497817 Free PMC article. Review. No abstract available.
Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies.
Jolles J, Verhey FR, Riedel WJ, Houx PJ. Jolles J, et al. Drugs Aging. 1995 Dec;7(6):459-79. doi: 10.2165/00002512-199507060-00006. Drugs Aging. 1995. PMID: 8601053 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information